Acorda Therapeutics
-
Global Fampridine Market to Reach $11.7 Million by 2036: Merz Therapeutics’ Strategic Acquisition and the Evolution of MS Care Pathways
Merz Therapeutics’ acquisition of Ampyra and Fampyra is driving the global fampridine market toward $11.7M by 2036, consolidating multiple sclerosis therapies.